News
Policy & Recommendations
Flash Report: Fourth meeting of the Public Health Expert Group (PHEG)
Representatives of EU Member States agreed on the launch of a call for best and promising practices on prevention, mapping of prevention policies and updating the Healthier Together guidance document by including new focus on lifelong prevention.
Vaccination reduces central nervous system IL-1β and memory deficits after COVID-19 in mice
Up to 25% of individuals infected with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) exhibit postacute cognitive sequelae.
Mobilising Healthcare Professionals to Champion Vaccination
The Coalition for Life Course Immunisation releases a podcast episode exploring the vital role of healthcare workers in enhancing vaccine acceptance across Europe. Hosted by Gary Finnegan, editor of Vaccines Today, with guest Dr. Angelos Kassianos.
A chimeric haemagglutinin-based universal influenza virus vaccine boosts human cellular immune responses directed towards the conserved haemagglutinin stalk domain and the viral nucleoprotein
The development of a universal influenza virus vaccine, to protect against both seasonal and pandemic influenza A viruses, is a long-standing public health goal.
|
9th Influenza Conference 2023
Scientific highlights of the 9th ESWI Influenza Conference
With promising developments in the field of respiratory viral infections, the conference sessions covered hot topics on seasonal, pandemic, and zoonotic influenza viruses, as well as other respiratory viruses such as RSV and SARS-CoV-2.
Understanding the gap between guidelines and influenza vaccination coverage in people with diabetes: a scoping review
Diabetes affects millions of people worldwide, making them more vulnerable to infections, including seasonal influenza. It is therefore particularly important for those suffering from diabetes to be vaccinated against influenza each year.
COVID-19 vaccine strain updates: Global regulators agree on timing and data requirements
International regulators have published a report presenting the outcomes of a workshop on COVID-19 vaccine strain updates that was organised by the International Coalition of Medicines Regulatory Authorities and the World Health Organization.
News
Scientific Papers
Article
Effectiveness of COVID-19 vaccines to prevent long COVID: data from Norway
tudy using data from more than 20 million participants has shown that COVID-19 vaccines consistently prevent long COVID symptoms in adults
Systematic review update on the efficacy, effectiveness and safety of newer and enhanced seasonal influenza vaccines for the prevention of laboratory confirmed influenza in individuals aged 18 years and over
The influenza landscape and vaccination coverage in older adults during theSARS-Cov-2 pandemic: data from Several European Countries and Israel
While influenza and the common cold are both contagious viral respiratory tract illnesses, influenza can be a serious disease that could lead to severe complications and unfavorable outcomes due to broader consequences.
|
ESWI Respiratory Virus Summit 2024
ESWI Respiratory Virus Summit 2024 recap video
The discussions highlighted the crucial role of prevention, treatment and access to immunisation programmes to raise awareness and decrease the cases of RSV hospitalisations and deaths of young children and older adults.
|
ESWI Respiratory Virus Summit 2024
ESWI Summit 2024: Conclusions
Conclusions by Peter Openshaw, Co-Chair of the the ESWI Respiratory Virus Summit 2024